These stocks are the most active in today's session
By Mill Chart
Last update: Jan 27, 2023
Let's have a look at the most active stocks in today's session.
Today's most active stocks
| Ticker | Change | Comment |
|---|---|---|
| XELA | -8.22% | 267.25M shares of EXELA TECHNOLOGIES INC (NASDAQ:XELA) have been traded so far today. Shares are falling by 8.22%. |
| TSLA | 10.53% | 218.18M shares of TESLA INC (NASDAQ:TSLA) have been traded so far today. The share price increased by 10.53%. |
| BZFD | 61.24% | So far 189.97M shares of BUZZFEED INC (NASDAQ:BZFD) have traded in today's session. Shares are rising by 61.24%. |
| MULN | 8.09% | MULLEN AUTOMOTIVE INC's (NASDAQ:MULN) traded a high volume of 162.3M shares. NASDAQ:MULN is advancing 8.09% today. Yesterday the company had a press release: Mullen Announces Key Hires Across EV Programs. |
| INTC | -7.26% | 112.5M shares of INTEL CORP (NASDAQ:INTC) exchanged hands today. Shares are falling by 7.26%. |
| COMS | -29.74% | COMSOVEREIGN HOLDING CORP's (NASDAQ:COMS) traded a high volume of 105.8M shares. Leading to a price decrease of 29.74%. |
| RDHL | 15.15% | REDHILL BIOPHARMA LTD-SP ADR's (NASDAQ:RDHL) traded a high volume of 94.47M shares. The share price increased by 15.15%. |
| AKAN | 32.14% | 88.8M shares of AKANDA CORP (NASDAQ:AKAN) have been traded so far today. Shares are rising by 32.14%. |
| HLBZ | -1.67% | HELBIZ INC's (NASDAQ:HLBZ) traded a high volume of 88.7M shares. Shares are falling by 1.67%. |
| LCID | 86.67% | 87.04M shares of LUCID GROUP INC (NASDAQ:LCID) exchanged hands today. Shares are rising by 86.67%. |
To see the full list of most active stocks you can use our most active stocks screener.
REDHILL BIOPHARMA LTD-SP ADR
NASDAQ:RDHL (5/10/2024, 7:16:00 PM)
After market: 0.4606 +0 (+0.5%)0.4583
+0 (+0.07%)
RDHL News
5 days ago - RedHill Biopharma Ltd.RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035The new Chinese patent for opaganib as a therapy for inhibition of single-stranded RNA virus replication (notably Ebola Disease Virus) is valid through 2035...
17 days ago - RedHill Biopharma Ltd.RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 StudyFirst patient enrolled in the global, 300-patient, Phase 2 adaptive platform trial arm of RHB-107 (upamostat)1 for early COVID-19 outpatient treatment, funded...
a month ago - RedHill Biopharma Ltd.RedHill Biopharma Announces Full-Year 2023 Results and Operational HighlightsRedHill continues corporate transformation to focus on U.S. government-funded pipeline development in underserved, sizeable therapeutic areas with a...
a month ago - RedHill Biopharma Ltd.RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered...
2 months ago - RedHill Biopharma Ltd.RedHill Announces New USPTO Patent Covering Talicia® Through 2034U.S. Patent and Trademark Office (USPTO) issues new patent covering Talicia1 as an all-in-one treatment of Helicobacter pylori (H. pylori), supporting Talicia...
2 months ago - RedHill Biopharma Ltd.RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures ProgramsThe U.S. government's Chemical Medical Countermeasures (Chem MCM) Program and Chemical Countermeasures Research Program (CCRP), managed respectively by...
3 months ago - Seeking AlphaRedHill Biopharma files to sell 10.6M ADS for holders (NASDAQ:RDHL)Read about RedHill Biopharma's filing of a prospectus for the resale of 10.6M ADSs, representing 400 shares each, by selling stockholders.
4 months ago - RedHill Biopharma Ltd.RedHill Biopharma Announces Closing of $8 Million Registered Direct Offering/PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has closed...
4 months ago - RedHill Biopharma Ltd.RedHill Biopharma Announces $8 Million Registered Direct Offering/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered...
4 months ago - Seeking AlphaRedHill gains on patent grant for Talicia for H. pylori treatment (NASDAQ:RDHL)RedHill Biopharma's new patent for Talicia, a method for eradicating H.
4 months ago - RedHill Biopharma Ltd.RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042USPTO issues new patent covering Talicia[1] as a method for eradicating H. pylori regardless of patient Body Mass Index (BMI)[2], supporting Talicia protection...
